Literature DB >> 18296502

Antiprion properties of prion protein-derived cell-penetrating peptides.

Kajsa Löfgren1, Anna Wahlström, Pontus Lundberg, Ulo Langel, Astrid Gräslund, Katarina Bedecs.   

Abstract

In prion diseases, the cellular prion protein (PrP(C)) becomes misfolded into the pathogenic scrapie isoform (PrP(Sc)) responsible for prion infectivity. We show here that peptides derived from the prion protein N terminus have potent antiprion effects. These peptides are composed of a hydrophobic sequence followed by a basic segment. They are known to have cell-penetrating ability like regular cell-penetrating peptides (CPPs), short peptides that can penetrate cellular membranes. Healthy (GT1-1) and scrapie-infected (ScGT1-1) mouse neuronal hypothalamic cells were treated with various CPPs, including the prion protein-derived CPPs. Lysates were analyzed for altered protein levels of PrP(C) or PrP(Sc). Treatment with the prion protein-derived CPPs mouse mPrP(1-28) or bovine bPrP(1-30) significantly reduced PrP(Sc) levels in prion-infected cells but had no effect on PrP(C) levels in noninfected cells. Further, presence of prion protein-derived CPPs significantly prolonged the time before infection was manifested when infecting GT1-1 cells with scrapie. Treatment with other CPPs (penetratin, transportan-10, or poly-L-arginine) or prion protein-derived peptides lacking CPP function (mPrP(23-28,) mPrP(19-30,) or mPrP(23-50)) had no effect on PrP(Sc) levels. The results suggest a mechanism by which the signal sequence guides the prion protein-derived CPP into a cellular compartment, where the basic segment binds specifically to PrP(Sc) and disables formation of prions.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18296502     DOI: 10.1096/fj.07-099549

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  10 in total

Review 1.  Biotherapeutic effect of cell-penetrating peptides against microbial agents: a review.

Authors:  Idris Zubairu Sadiq; Aliyu Muhammad; Sanusi Bello Mada; Bashiru Ibrahim; Umar Aliyu Umar
Journal:  Tissue Barriers       Date:  2021-10-25

Review 2.  Cell-Penetrating Peptides with Unexpected Anti-Amyloid Properties.

Authors:  Nicklas Österlund; Sebastian K T S Wärmländer; Astrid Gräslund
Journal:  Pharmaceutics       Date:  2022-04-09       Impact factor: 6.525

3.  Bioportide: an emergent concept of bioactive cell-penetrating peptides.

Authors:  John Howl; Sabine Matou-Nasri; David C West; Michelle Farquhar; Jiřina Slaninová; Claes-Göran Ostenson; Matjaz Zorko; Pernilla Ostlund; Shant Kumar; Ulo Langel; Jane McKeating; Sarah Jones
Journal:  Cell Mol Life Sci       Date:  2012-04-20       Impact factor: 9.261

4.  A class of human proteins that deliver functional proteins into mammalian cells in vitro and in vivo.

Authors:  James J Cronican; Kevin T Beier; Tina N Davis; Jen-Chieh Tseng; Weida Li; David B Thompson; Allen F Shih; Erin M May; Constance L Cepko; Andrew L Kung; Qiao Zhou; David R Liu
Journal:  Chem Biol       Date:  2011-07-29

Review 5.  Cellular aspects of prion replication in vitro.

Authors:  Andrea Grassmann; Hanna Wolf; Julia Hofmann; James Graham; Ina Vorberg
Journal:  Viruses       Date:  2013-01-22       Impact factor: 5.048

6.  Mechanisms of cellular uptake of cell-penetrating peptides.

Authors:  Fatemeh Madani; Staffan Lindberg; Ulo Langel; Shiroh Futaki; Astrid Gräslund
Journal:  J Biophys       Date:  2011-04-07

7.  Cell-Penetrating Peptides Selectively Cross the Blood-Brain Barrier In Vivo.

Authors:  Sofie Stalmans; Nathalie Bracke; Evelien Wynendaele; Bert Gevaert; Kathelijne Peremans; Christian Burvenich; Ingeborgh Polis; Bart De Spiegeleer
Journal:  PLoS One       Date:  2015-10-14       Impact factor: 3.240

8.  Transgenic Overexpression of the Disordered Prion Protein N1 Fragment in Mice Does Not Protect Against Neurodegenerative Diseases Due to Impaired ER Translocation.

Authors:  Behnam Mohammadi; Luise Linsenmeier; Mohsin Shafiq; Berta Puig; Giovanna Galliciotti; Camilla Giudici; Michael Willem; Thomas Eden; Friedrich Koch-Nolte; Yu-Hsuan Lin; Jörg Tatzelt; Markus Glatzel; Hermann C Altmeppen
Journal:  Mol Neurobiol       Date:  2020-05-04       Impact factor: 5.590

9.  Pathologic prion protein infects cells by lipid-raft dependent macropinocytosis.

Authors:  Jehangir S Wadia; Monica Schaller; R Anthony Williamson; Steven F Dowdy
Journal:  PLoS One       Date:  2008-10-02       Impact factor: 3.240

Review 10.  Building Cell Selectivity into CPP-Mediated Strategies.

Authors:  Irene Martín; Meritxell Teixidó; Ernest Giralt
Journal:  Pharmaceuticals (Basel)       Date:  2010-05-14
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.